Skip to main content
CSL Logo
  • Partnering
  • Contact
  • Our Company
    Our Company
    Our Story
    Corporate Responsibility
    In The Community
    In The Community
    Patient Support Groups
    Access to Medicines
    Disaster Relief
    Promoting Excellence in Science
    Next Generation of Researchers
    Board and Management
    Board and Management
    Global Leadership Group
    Corporate Governance
    Corporate Governance
    Code of Responsible Business Practice
    Core Policies

    The Commonwealth Serum Laboratories was established in Australia in 1916.

    Read Our Story

    At CSL, Corporate Responsibility is about conducting our business ethically.

    See What Goes into Our CR
  • Expertise
    Expertise
    Rare and Serious Diseases
    Influenza Vaccines and Antivenoms

    We offer the broadest range of quality plasma-derived and recombinant therapies in the industry.

    Rare & Serious Diseases

    Seqirus opened in 2015 and is the second largest influenza company in the world.

    Influenza Vaccines & Antivenoms
  • R&D
    R&D
    R&D Capabilities
    Product Pipeline
    Clinical Studies at CSL
    Clinical Studies at CSL
    Current Clinical Trials
    Research Practices
    What is a Clinical Trial
    What is a Clinical Trial
    Rights and Responsibilities
    Enrolling in a Clinical Trial
    FAQs
    Questions to Ask the Study Team

    Innovation has been in the DNA of CSL since our beginning in 1916

    Learn More

    Our product portfolio focuses on innovation in new products

    Learn More
  • Investors
    Investors
    CSL Share Price
    Financial Results and Information
    Financial Results and Information
    Five Year Summary
    Debt Information
    Annual Reports
    Financial Calendar
    ASX Announcements
    Presentations
    Dividends
    Shareholder Information
    Shareholder Information
    Shareholder Inquiries
    Contact Us

    Our interim dividend for 2020 was US$0.95 per share, up 12%.

    Learn More

    Our exceptionally strong performance is a result of the focused execution of our strategy.

    Learn More
  • Careers
    Careers
    See Yourself at CSL
    Diversity & Inclusion
    How We Care for You at CSL
    Discover Our People

    Help us deliver on our promise to save lives and protect the health of people.

    See Yourself at CSL

    Diversity and inclusion are top priorities for CSL.

    See Why We Embrace Them
  • News
    News
    Newsroom

    View our ASX announcements

    ASX announcements

    Visit this page to see all of our current news releases

    Newsroom
CSL
  • Our Company
    • Our Company
    • Our Story
    • Corporate Responsibility
    • In The Community
      • In The Community
      • Patient Support Groups
      • Access to Medicines
      • Disaster Relief
      • Promoting Excellence in Science
      • Next Generation of Researchers
    • Board and Management
      • Board and Management
      • Global Leadership Group
    • Corporate Governance
      • Corporate Governance
      • Code of Responsible Business Practice
      • Core Policies
  • Expertise
    • Expertise
    • Rare and Serious Diseases
    • Influenza Vaccines and Antivenoms
  • Research & Development
    • Research & Development
    • R&D Capabilities
    • Product Pipeline
    • Clinical Studies at CSL
      • Clinical Studies at CSL
      • Current Clinical Trials
      • Research Practices
    • What is a Clinical Trial
      • What is a Clinical Trial
      • Rights and Responsibilities
      • Enrolling in a Clinical Trial
      • FAQs
      • Questions to Ask the Study Team
  • Investors
    • Investors
    • CSL Share Price
    • Financial Results and Information
      • Financial Results and Information
      • Five Year Summary
      • Debt Information
      • Annual Reports
      • Financial Calendar
    • ASX Announcements
    • Presentations
    • Dividends
    • Shareholder Information
      • Shareholder Information
      • Shareholder Inquiries
      • Contact Investor Relations
  • Careers
    • Careers
    • See Yourself at CSL
    • Diversity & Inclusion
    • How We Care for You at CSL
    • Discover Our People
  • News
    • News
    • Newsroom
  • Partnering
  • Contact
Picture of a scientist at a work station

CSL Research Acceleration Initiative

Registrations for the 2020 CSL Research Acceleration Initiative are now closed.

Thank you to all the research organisations that have registered to participate.

If you are interested in registering your research organisation for future Research Acceleration Initiatives, please email RAI@csl.com.au

  • Contact
CSL Logo
  • LinkedIn
  • Twitter
  • YouTube

CSL Limited, All Rights Reserved © 2020

  • Contact
CSL Logo
  • LinkedIn
  • Twitter
  • YouTube
  • Contact
  • Glossary
  • Sitemap
  • Privacy Policy
  • Terms of Use
  • Employees

CSL Limited, All Rights Reserved © 2020

Popular search terms:

  • financial results
  • annual report
  • half year 2020
  • share price
  • news

Corporate

  • CSL Behring (Global)

Seqirus

  • Global

Americas

  • United States

Asia Pacific

  • Australia
  • New Zealand

Europe

  • Germany
  • Italy

CSL Behring Worldwide

Americas

  • Argentina
  • Brazil
  • Canada
  • Chile
  • CSL Behring Global
  • CSL Plasma (US)
  • Mexico

Asia Pacific

  • Australia
  • China
  • Japan

Europe

  • Austria
  • Belgium and Luxembourg
  • CSL Plasma Services (Germany)
  • Czech Republic
  • Denmark
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Italy
  • Netherlands
  • Norway
  • Poland
  • Russia
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Kingdom